According to Myovant Sciences 's latest financial reports the company's current revenue (TTM) is $0.37 B. In 2021 the company made a revenue of $0.19 B an increase over the years 2020 revenue that were of $34.71 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $0.37 B | 91.46% |
2021 | $0.19 B | 470.44% |
2020 | $34.71 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |